  <ichicsr lang="en">

      <ichicsrmessageheader>

        <messagetype>ichicsr</messagetype>

        <messageformatversion>2.1</messageformatversion>
        
        <messageformatrelease>2.0</messageformatrelease>
        
        <messagenumb>236908_TRN</messagenumb>
        
        <messagesenderidentifier></messagesenderidentifier>
        
        <messagereceiveridentifier></messagereceiveridentifier>
        
        <messagedateformat>204</messagedateformat>
        
        <messagedate>20140208133736</messagedate>

      </ichicsrmessageheader>

      <safetyreport>

       <safetyreportversion>1</safetyreportversion>

       <safetyreportid></safetyreportid>

       <primarysourcecountry>US</primarysourcecountry>

       <occurcountry>US</occurcountry>

       <transmissiondateformat>102</transmissiondateformat>

       <transmissiondate>20140212</transmissiondate>

       <reporttype>2</reporttype>

       <serious>1</serious>

       <seriousnessdeath>2</seriousnessdeath>

       <seriousnesslifethreatening>2</seriousnesslifethreatening>

       <seriousnesshospitalization>1</seriousnesshospitalization>

       <seriousnessdisabling>2</seriousnessdisabling>

       <seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>

       <seriousnessother>1</seriousnessother>

       <receivedateformat>102</receivedateformat>

       <receivedate>20130804</receivedate>

       <receiptdateformat>102</receiptdateformat>

       <receiptdate>20130804</receiptdate>

       <additionaldocument>2</additionaldocument>

       <fulfillexpeditecriteria>1</fulfillexpeditecriteria>

       <companynumb></companynumb>

        <primarysource>

         <reporterfamilyname></reporterfamilyname>

         <reporterorganization></reporterorganization>

         <reporterstreet></reporterstreet>

         <reporterpostcode></reporterpostcode>

         <reportercountry></reportercountry>

         <qualification>3</qualification>

         <studyname>2007-005837-13#COU-AA-301</studyname>

         <sponsorstudynumb>COU-AA-301</sponsorstudynumb>

         <observestudytype>1</observestudytype>

        </primarysource>

        <sender>

         <sendertype>1</sendertype>

         <senderorganization></senderorganization>

         <senderdepartment></senderdepartment>

         <sendergivename></sendergivename>

         <senderfamilyname></senderfamilyname>

         <senderstreetaddress></senderstreetaddress>

         <sendercity></sendercity>

         <senderstate></senderstate>

         <senderpostcode></senderpostcode>

         <sendercountrycode></sendercountrycode>

         <sendertel>12345678</sendertel>

         <sendertelcountrycode>1</sendertelcountrycode>

         <senderfax>45678901</senderfax>

         <senderfaxcountrycode>1</senderfaxcountrycode>

        </sender>

        <receiver>

         <receivertype>2</receivertype>

         <receiverorganization></receiverorganization>

         <receivergivename></receivergivename>

         <receiverfamilyname></receiverfamilyname>

         <receivercountrycode></receivercountrycode>

         <receiverfax>1919998796</receiverfax>

         <receiveremailaddress>first.last@email.com</receiveremailaddress>

        </receiver>

        <patient>

         <patientinvestigationnumb>001-002</patientinvestigationnumb>

         <patientbirthdateformat>102</patientbirthdateformat>

         <patientbirthdate>19490401</patientbirthdate>

         <patientsex>1</patientsex>

         <resultstestsprocedures>Chest x-ray: xyz</resultstestsprocedures>

          <medicalhistoryepisode>

           <patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>

           <patientepisodename>Hypertension</patientepisodename>

           <patientmedicalstartdateformat>102</patientmedicalstartdateformat>

           <patientmedicalstartdate>20010523</patientmedicalstartdate>

           <patientmedicalcontinue>2</patientmedicalcontinue>

           <patientmedicalenddateformat>102</patientmedicalenddateformat>

           <patientmedicalenddate>20041229</patientmedicalenddate>

          </medicalhistoryepisode>

          <patientpastdrugtherapy>

           <patientdrugname>PARACETAMOL</patientdrugname>

           <patientdrugstartdateformat>102</patientdrugstartdateformat>

           <patientdrugstartdate>20030829</patientdrugstartdate>

           <patientindicationmeddraversion>15.1</patientindicationmeddraversion>

           <patientdrugindication>Headache</patientdrugindication>

           <patientdrgreactionmeddraversion>15.1</patientdrgreactionmeddraversion>

           <patientdrugreaction>Rash</patientdrugreaction>

          </patientpastdrugtherapy>

          <reaction>

           <primarysourcereaction>heart attack</primarysourcereaction>

           <reactionmeddraversionllt>15.1</reactionmeddraversionllt>

           <reactionmeddrallt>Heart attack</reactionmeddrallt>

           <reactionmeddraversionpt>15.1</reactionmeddraversionpt>

           <reactionmeddrapt>Myocardial infarction</reactionmeddrapt>

           <reactionstartdateformat>102</reactionstartdateformat>

           <reactionstartdate>20130803</reactionstartdate>

           <reactionenddateformat>102</reactionenddateformat>

           <reactionenddate>20130803</reactionenddate>

           <reactionduration>1</reactionduration>

           <reactiondurationunit>804</reactiondurationunit>

           <reactionfirsttime>69</reactionfirsttime>

           <reactionfirsttimeunit>804</reactionfirsttimeunit>

           <reactionlasttime>65</reactionlasttime>

           <reactionlasttimeunit>804</reactionlasttimeunit>

           <reactionoutcome>1</reactionoutcome>

          </reaction>

          <reaction>

           <primarysourcereaction>sepsis</primarysourcereaction>

           <reactionmeddraversionllt>15.1</reactionmeddraversionllt>

           <reactionmeddrallt>Sepsis</reactionmeddrallt>

           <reactionmeddraversionpt>15.1</reactionmeddraversionpt>

           <reactionmeddrapt>Sepsis</reactionmeddrapt>

           <reactionstartdateformat>102</reactionstartdateformat>

           <reactionstartdate>20130801</reactionstartdate>

           <reactionfirsttime>67</reactionfirsttime>

           <reactionfirsttimeunit>804</reactionfirsttimeunit>

           <reactionlasttime>63</reactionlasttime>

           <reactionlasttimeunit>804</reactionlasttimeunit>

           <reactionoutcome>3</reactionoutcome>

          </reaction>

          <test>

           <testdateformat>102</testdateformat>

           <testdate>20010322</testdate>

           <testname>10061576</testname>

           <testresult>22</testresult>

           <testunit>µg/l</testunit>

           <lowtestrange>0</lowtestrange>

           <hightestrange>10</hightestrange>

           <moreinformation>1</moreinformation>

          </test>

          <test>

           <testdateformat>102</testdateformat>

           <testdate>20130323</testdate>

           <testname>10061576</testname>

           <testresult>26</testresult>

           <testunit>µg/l</testunit>

           <lowtestrange>0</lowtestrange>

           <hightestrange>10</hightestrange>

           <moreinformation>2</moreinformation>

          </test>

          <test>

           <testdateformat>102</testdateformat>

           <testdate>20010322</testdate>

           <testname>10008498</testname>

           <moreinformation>1</moreinformation>

          </test>

          <drug>

           <drugcharacterization>1</drugcharacterization>

           <medicinalproduct>ABIRATERONE ACETATE</medicinalproduct>

           <obtaindrugcountry>US</obtaindrugcountry>

           <drugauthorizationnumb>111,878</drugauthorizationnumb>

           <drugauthorizationcountry>US</drugauthorizationcountry>

           <drugstructuredosagenumb>10</drugstructuredosagenumb>

           <drugstructuredosageunit>003</drugstructuredosageunit>

           <drugseparatedosagenumb>1</drugseparatedosagenumb>

           <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>

           <drugintervaldosagedefinition>804</drugintervaldosagedefinition>

           <drugcumulativedosagenumb>50</drugcumulativedosagenumb>

           <drugcumulativedosageunit>003</drugcumulativedosageunit>

           <drugdosagetext>10 mg, qd</drugdosagetext>

           <drugdosageform>Tablet</drugdosageform>

           <drugadministrationroute>048</drugadministrationroute>

           <drugindicationmeddraversion>15.1</drugindicationmeddraversion>

           <drugindication>10060862</drugindication>

           <drugstartdateformat>102</drugstartdateformat>

           <drugstartdate>20130527</drugstartdate>

           <drugenddateformat>102</drugenddateformat>

           <drugenddate>20130531</drugenddate>

           <drugtreatmentduration>5</drugtreatmentduration>

           <drugtreatmentdurationunit>804</drugtreatmentdurationunit>

           <actiondrug>4</actiondrug>

            <activesubstance>

             <activesubstancename>ABIRATERONE ACETATE</activesubstancename>

            </activesubstance>

            <drugreactionrelatedness>

             <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>

             <drugreactionasses>Myocardial infarction</drugreactionasses>

             <drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>

             <drugresult>Related</drugresult>

            </drugreactionrelatedness>

            <drugreactionrelatedness>

             <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>

             <drugreactionasses>Myocardial infarction</drugreactionasses>

             <drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>

             <drugresult>Related</drugresult>

            </drugreactionrelatedness>

            <drugreactionrelatedness>

             <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>

             <drugreactionasses>Sepsis</drugreactionasses>

             <drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>

             <drugresult>Not Related</drugresult>

            </drugreactionrelatedness>

            <drugreactionrelatedness>

             <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>

             <drugreactionasses>Sepsis</drugreactionasses>

             <drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>

             <drugresult>Not Related</drugresult>

            </drugreactionrelatedness>

          </drug>

          <drug>

           <drugcharacterization>1</drugcharacterization>

           <medicinalproduct>ABIRATERONE ACETATE</medicinalproduct>

           <obtaindrugcountry>US</obtaindrugcountry>

           <drugauthorizationnumb>111,878</drugauthorizationnumb>

           <drugauthorizationcountry>US</drugauthorizationcountry>

           <drugcumulativedosagenumb>50</drugcumulativedosagenumb>

           <drugcumulativedosageunit>003</drugcumulativedosageunit>

           <drugdosagetext>UNK</drugdosagetext>

           <drugdosageform>Tablet</drugdosageform>

           <actiondrug>4</actiondrug>

            <activesubstance>

             <activesubstancename>ABIRATERONE ACETATE</activesubstancename>

            </activesubstance>

            <drugreactionrelatedness>

             <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>

             <drugreactionasses>Myocardial infarction</drugreactionasses>

             <drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>

             <drugresult>Related</drugresult>

            </drugreactionrelatedness>

            <drugreactionrelatedness>

             <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>

             <drugreactionasses>Myocardial infarction</drugreactionasses>

             <drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>

             <drugresult>Related</drugresult>

            </drugreactionrelatedness>

            <drugreactionrelatedness>

             <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>

             <drugreactionasses>Sepsis</drugreactionasses>

             <drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>

             <drugresult>Not Related</drugresult>

            </drugreactionrelatedness>

            <drugreactionrelatedness>

             <drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>

             <drugreactionasses>Sepsis</drugreactionasses>

             <drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>

             <drugresult>Not Related</drugresult>

            </drugreactionrelatedness>

          </drug>

          <drug>

           <drugcharacterization>2</drugcharacterization>

           <medicinalproduct>PREDNISONE</medicinalproduct>

           <drugrecurreadministration>3</drugrecurreadministration>

            <activesubstance>

             <activesubstancename>PREDNISONE</activesubstancename>

            </activesubstance>

          </drug>

          <summary>

           <narrativeincludeclinical>Sample Patient Narraive</narrativeincludeclinical>

          </summary>

        </patient>

      </safetyreport>
</ichicsr>